|
ASCHELE C.-CIONINI L.-LONARDI S.-PINTO C.-CORDIO S.-ROSATI G.-
ARTALE S.-TAGLIAGAMBE A.-AMBROSINI G.-ROSETTI P.-BONETTI A.-NEGRU
M.-TRONCONI M.-LUPPI G.-SILVANO G.-CORSI D.-BOCHICCHIO A.-CHIAULON
G.-GALLO M.-BONI L.
Primary tumor response to preoperative chemoradiation with or
without oxaliplatin in locally advanced rectal cancer: pathologic
results of the STAR/01 randomized phase III trial.
J. Clin. Oncol. 29(20):2773/2780, 2011
PubMed Abstract
BARBORO P.-REPACI E.-FERRARI N.-RUBAGOTTI A.-BOCCARDO F.-BALBI C.
Androgen receptor and heterogeneous nuclear ribonucleoprotein K
colocalize in the nucleoplasm and are modulated by bicalutamide
and 4/hydroxy/tamoxifen in prostatic cancer cell lines.
Prostate 71:1466/1479, 2011
PubMed Abstract
BEDOGNETTI D.-ZOPPOLI G.-MASSUCCO C.-ZANARDI E.-ZUPO S.-BRUZZONE
A.-SERTOLI M.R.-BALLEARI E.-RACCHI O.-MESSINA M.-CALTABIANO G.-
ICARDI G.-DURANDO P.-MARINCOLA F.-BOCCARDO F.-FERRARINI M.-ANSALDI
F.-DE MARIA A.
Impaired response to influenza vaccine associated with persistent
memory B cell depletion in non Hodgkin's lymphoma patients treated
with rituximab containing regimens.
J. Immunol. 186:6044/6055, 2011
PubMed Abstract
BOCCARDO F.-GUGLIELMINI P.-PARODI A.-RUBAGOTTI A.
Chemotherapy versus tamoxifen versus chemotherapy plus tamoxifen
in node positive, oestrogen receptor/positive breast cancer
patients. Very late results of the Gruppo di Ricerca per la Chemio
Ormonoterapia Adiuvante (GROCTA) 01/Trial in early breast cancer.
Breast Cancer Res. Treat. 126:653/661, 2011
PubMed Abstract
SMITH I.E.-PIERGA J.-BIGANZOLI L.-CORTES FUNES H.-THOMSSEN C.-
PIVOT X.-FABI A.-XU B.-STROYAKOVSKIY D.-FRANKE F.-KAUFMAN B.-
MAINWARING P.-PIENKOWSKI T.-DE VALK B.-KWONG A.-GONZALEZ TRUJILLO
J.-KOZA I.-PETRAKOVA K.-PEREIRA D.-PRITCHARD K.-ATHENA Study Group-
DEL MASTRO L.-SERTOLI M.R.
First line bevacizumab plus taxane based chemotherapy for locally
recurrent or metastatic breast cancer: safety and efficacy in an
open label study in 2251 patients.
Ann. Oncol. 22:595/602, 2011
PubMed Abstract
AMADORI D.-SILVESTRINI R.-DE LENA M.-BOCCARDO F.-ROCCA A.-SCARPI
E.-SCHITTULLI F.-BRANDI M.-MALTONI R.-SERRA P.-PONZONE R.-BIGLIA
N.-GIANNI L.-TIENGHI A.-VALERIO M.-BONGINELLI P.-AMADUCCI L.-FAEDI
M.-BALDINI E.-PARADISO A.
Randomized phase III trial of adjuvant epirubicin followed by
cyclophosphamide, methotrexate, and 5/fluorouracil (CMF) versus
CMF followed by epirubicin in patients with node negative or 1/3
node positive rapidly proliferating breast cancer.
Breast Cancer Res. Treat. 125:775/784, 2011 - Epub Dec 4, 2010
PubMed Abstract
BEDOGNETTI D.-RUBAGOTTI A.-ZOPPOLI G.-BOCCARDO F.
Gynaecomastia: the anastrozole paradox. Letter.
J. Pediatr. Endocrinol. Metab. 23(1/2):205/206, 2010
PubMed Abstract
BEDOGNETTI D.-WANG E.-SERTOLI M.R.-MARINCOLA F.
Gene expression profiling in vaccine therapy and immunotherapy for cancer.
Expert Rev. Vaccines 9(6):555/565, 2010
PubMed Abstract
BEDOGNETTI D.-ZOPPOLI G.-SERTOLI M.R.-ZANARDI E.-BLANDINI P.-
UCCELLINI L.-BOCCARDO F.-ANDREOLI G.B.-GHIO R.-RACCHI O.-FERRARINI
M.-DE MARIA A.
Relevance of HBV/HBcAb screening in lymphoma patients treated in
the Rituximab era. Letter.
Int. J. Hematol. 91:342/344, 2010
PubMed Abstract
BOCCARDO F.-AMADORI D.-GUGLIELMINI P.-SISMONDI P.-FARRIS A.-
AGOSTARA B.-GAMBI A.-CATALANO Gi.-FAEDI M.-RUBAGOTTI A.
Epirubicin followed by cyclophosphamide, methotrexate and
5/fluorouracil versus paclitaxel followed by epirubicin and
vinorelbine in patients with high risk operable breast cancer.
Oncology 78:274/281, 2010
PubMed Abstract
CORREA C.-MCGALE P.-TAYLOR C.-WANG Y.-CLARKE M.-DAVIES C.-PETO R.-
BIJKER N.-SOLIN L.-DARBY S.-Early Breast Cancer Trialists'
Collaborative Group (EBCTCG)-BOCCARDO F.-RUBAGOTTI A.-BRUZZI P.-
DEL MASTRO L.-PRONZATO P.-SERTOLI M.R.-VENTURINI M.
Overview of the randomized trials of radiotherapy in ductal
carcinoma in situ of the breast.
J. Natl. Cancer Inst. Monogr. 2010(41):162/177, 2010
PubMed Abstract
DEL VECCHIO M.-MORTARINI R.-CANOVA S.-DI GUARDO L.-PIMPINELLI N.-
SERTOLI M.R.-BEDOGNETTI D.-QUEIROLO P.-MOROSINI P.-PERRONE T.-
BAJETTA E.-ANICHINI A.
Bevacizumab plus fotemustine as first line treatment in metastatic
melanoma patients: clinical activity and modulation of
angiogenesis and lymphangiogenesis factors.
Clin. Cancer Res. 16(23):5862/5872, 2010
PubMed Abstract
GERARD J.-FRANCOIS E.-FREYER G.-MILANO G.-ASCHELE C.
Rectal cancer: rectal preservation is an important end point.
Letter.
J. Clin. Oncol. 28(29):e581/e583, 2010
MOTZER R.J.-ESCUDIER B.-OUDARD S.-HUTSON T.-PORTA C.-BRACARDA S.-
GRUNWALD V.-THOMPSON J.-FIGLIN R.-HOLLAENDER N.-KAY A.-RAVAUD A.-
RECORD/1 Study Group-BOCCARDO F.
Phase 3 trial of everolimus for metastatic renal cell carcinoma.
Final results and analysis of prognostic factors.
Cancer 116:4256/4265, 2010
PubMed Abstract
BARBORO P.-REPACI E.-RUBAGOTTI A.-SALVI S.-BOCCARDO S.-SPINA B.-
TRUINI M.-INTROINI C.-PUPPO P.-FERRARI N.-CARMIGNANI G.-BOCCARDO
F.-BALBI C.
Heterogeneous nuclear ribonucleoprotein K: altered pattern of
expression associated with diagnosis and prognosis of prostate
cancer.
Br. J. Cancer 100:1608/1616, 2009
PubMed Abstract
BEDOGNETTI D.-RUBAGOTTI A.-CONTI G.-FRANCESCA F.-DE COBELLI O.-
CANCLINI L.-GALLUCCI M.-ARAGONA F.-DI TONNO P.-CORTELLINI P.-
MARTORANA G.-LAPINI A.-BOCCARDO F.
An open, randomised, multicentre, phase 3 trial comparing the
efficacy of two tamoxifen schedules in preventing gynaecomastia
induced by bicalutamide monotherapy in prostate cancer patients.
Eur. Urol. 57:238/245, 2010 - Epub May 19, 2009
PubMed Abstract
DOWSETT M.-CUZICK J.-INGLE J.-COATES A.-FORBES J.-BLISS J.-BUYSE
M.-BAUM M.-BUZDAR A.-COLLEONI M.-COOMBES C.-SNOWDON C.-GNANT M.-
JAKESZ R.-KAUFMANN M.-BOCCARDO F.-GODWIN J.-DAVIES C.-PETO R.
Meta analysis of breast cancer outcomes in adjuvant trials of
aromatase inhibitors versus tamoxifen.
J. Clin. Oncol. 28:509/518, 2010 - Epub Nov 30, 2009
PubMed Abstract
GILIBERTO L.-BORGHI R.-PICCINI A.-MANGERINI R.-SORBI S.-CIRMENA G.-
GARUTI A.-GHETTI B.-TAGLIAVINI F.-MUGHAL M.-MATTSON M.-ZHU X.-WANG
X.-GUGLIELMOTTO M.-TAMAGNO E.-TABATON M.
Mutant presenilin 1 increases the expression and activity of BACE1.
J. Biol. Chem. 284:9027/9038, 2009
PubMed Abstract
MANGERINI R.-LANINO E.-TERRANOVA P.-FARACI M.-PISTILLO M.P.-
GAETANI G.F.-FERRARIS A.M.
Telomere length of donors influences granulocyte recovery in
children after hematopoietic stem cell transplantation. Letter.
Ann. Hematol. 88:1029/1031, 2009
PubMed Abstract
MIGLIETTA L.-VANELLA P.-CANOBBIO L.-PARODI M.-GUGLIELMINI P.-
BOCCARDO F.
Clinical and pathological response to primary chemotherapy in
patients with locally advanced breast cancer grouped according to
hormonal receptors, Her2 status, grading and Ki/67 proliferation
index.
Anticancer Res. 29:1621/1626, 2009
PubMed Abstract
PICCIOLI P.-BALBI G.-SERRA M.-MORABITO A.-LAMPARELLI T.-GOBBI M.-
LAURENT S.-DOZIN B.-BRUZZI P.-FERRARIS A.M.-BACIGALUPO An.-NOTARO
R.-PISTILLO M.P.
CTLA/4 +49A>G polymorphism of recipients of HLA matched sibling
allogeneic stem cell transplantation is associated with survival
and relapse incidence.
Ann. Hematol. 89:613/618, 2010 - Epub Dec 18, 2009
PubMed Abstract
REPETTO L.-PISELLI P.-RAFFAELE M.-LOCATELLI C.-GIOGer-BOCCARDO F.-
PRONZATO P.
Communicating cancer diagnosis and prognosis: when the target is
the elderly patient. A GIOGer study.
Eur. J. Cancer 45:374/383, 2009
PubMed Abstract
BARBORO P.-RUBAGOTTI A.-ORECCHIA P.-SPINA B.-TRUINI M.-REPACI E.-CARMIGNANI G.-ROMAGNOLI
A.-INTROINI C.-BOCCARDO F.-CARNEMOLLA B.-BALBI C.
Differential proteomic analysis of nuclear matrix in muscle invasive
bladder cancer: potential to improve diagnosis and prognosis.
Cell. Oncol. 30:13/26, 2008
PubMed Abstract
BOCCARDO F.
Switching to anastrozole after tamoxifen improves survival in postmenopausal
women with breast cancer.
Nat. Clin. Pract. Oncol. 5:76/77, 2008
PubMed Abstract
BOCCARDO F.-RUBAGOTTI A.-CONTI G.-BATTAGLIA M.-CRUCIANI G.-
MANGANELLI A.-RICCI S.-LAPINI A.
Prednisone plus gefitinib versus prednisone plus placebo in the
treatment of hormone refractory prostate cancer: a randomized
phase II trial.
Oncology 74:223/228, 2008
PubMed Abstract
CATANIA C.-ZAGONEL V.-FOSSER V.-LA VERDE N.-BERTETTO O.-IACONO C.-
VENTURINI M.-RADICE D.-ADAMOLI L.-BOCCARDO F.
Opinions concerning euthanasia, life sustaining treatment and
acceleration of death: results of an Italian Association of
Medical Oncology (AIOM) survey.
Ann. Oncol. 19:1947/1954, 2008
PubMed Abstract
EGGERMONT A.-SUCIU S.-SANTINAMI M.-TESTORI A.-KRUIT W.-MARSDEN J.-
PUNT C.-SALES F.-GORE M.-MacKIE R.-KUSIC Z.-DUMMER R.-HAUSCHILD A.-
MUSAT E.-SPATZ A.-KEILHOLZ U.-EORTC Melanoma Group-SERTOLI M.R.-
QUEIROLO P.
Adjuvant therapy with pegylated interferon alfa/2b versus
observation alone in resected stage III melanoma: final results of
EORTC 18991, a randomised phase III trial.
Lancet 372:117/126, 2008
PubMed Abstract
MOTZER R.-ESCUDIER B.-OUDARD S.-HUTSON T.-PORTA C.-BRACARDA S.-
GRUNWALD V.-THOMPSON J.-FIGLIN R.-HOLLAENDER N.-URBANOWITZ G.-BERG
W.-KAY A.-LEBWOHL D.-RAVAUD A.-RECORD 1 Study Group-BOCCARDO F.
Efficacy of everolimus in advanced renal cell carcinoma: a double
blind, randomised, placebo controlled phase III trial.
Lancet 372:449/456, 2008
PubMed Abstract
VERZOLA D.-GANDOLFO M.-GAETANI G.-FERRARIS A.-MANGERINI R.-
FERRARIO F.-VILLAGGIO B.-GIANIORIO F.-TOSETTI Fa.-WEISS U.-
TRAVERSO P.-MJI M.-DEFERRARI G.-GARIBOTTO G.
Accelerated senescence in the kidneys of patients with type 2
diabetic nephropathy.
Am. J. Physiol. Renal Physiol. 295:F1563/F1573, 2008
PubMed Abstract
BOCCARDO F.-RUBAGOTTI A.
Switching to aromatase inhibitors in early breast cancer.
Lancet 369:533/535, 2007
PubMed Abstract
BOCCARDO F.-RUBAGOTTI A.-ALDRIGHETTI D.-BUZZI F.-CRUCIANI G.-FARRIS A.-MUSTACCHI G.-PORPIGLIA M.-SCHIEPPATI G.-SISMONDI P.
Switching to an aromatase inhibitor provides mortality benefit in early breast carcinoma. Pooled analysis of 2 consecutive trials.
Cancer 109:1060/1067, 2007
PubMed Abstract
GHIORZO P.-GARGIULO S.-NASTI S.-PASTORINO L.-BATTISTUZZI
L.-BRUNO W.-BONELLI L.-TAVEGGIA P.-PUGLIESE V.-BORGONOVO G.-MASTRACCI L.-
FORNARINI G.-ROMAGNOLI P.-IIRITANO E.-SAVARINO V.-BIANCHI SCARRA' G.
Predicting the risk of pancreatic cancer: on CDKN2A mutations in the
melanoma pancreatic cancer syndrome in Italy. Letter.
J. Clin. Oncol. 25:5336/5337, 2007
PubMed Abstract LHRH/Agonists Early Breast Cancer Overview Group-BOCCARDO F.-RUBAGOTTI A.
Use of luteinising hormone releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone receptor positive
breast cancer: a meta analysis of individual patient data from randomised adjuvant trials.
Lancet 369:1711/1723, 2007
PubMed Abstract MATTEI D.-BASSAN R.-MORDINI N.-RAPEZZI D.-RAMBALDI A.-STROLA G.-
PERETTI C.-DEL GROSSO F.-FERRARIS A.M.-CASTELLINO C.-GALLAMINI A.
Expansion of B cell precursors after unrelated cord blood
transplantation for an adult patient. Letter.
Bone Marrow Transplant. 40:283/285, 2007
BAJETTA E.-DEL VECCHIO M.-NOVA P.-FUSI A.-DAPONTE A.-SERTOLI M.R.-QUEIROLO P.-TAVEGGIA P.-BERNENGO M.-LEGHA S.-
FORMISANO B.-CASCINELLI N.
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous
interleukin/2 and interferon alpha2b in metastatic melanoma.
Ann. Oncol. 17:571/577, 2006
PubMed Abstract BENASSO M.-PONZANELLI A.-MERLANO M.-NUMICO G.-RICCI I.-VIGO V.-GROSSI F.-AMADORI D.-CAVALLO G.-CAPACCETTI B.-TAVEGGIA P.-BONI L.-ROSSO R.
Paclitaxel, cisplatin and 5/fluorouracil in recurrent squamous cell carcinoma of the head and neck: a phase II trial from an italian cooperative group.
Acta Oncol. 45:168/174, 2006
PubMed Abstract BOCCARDO F.-GUGLIELMINI P.-TACCHINI L.
Medical treatment of advanced renal cell carcinoma: present options and future directions.
Eur. Urol. 5(suppl):619/626, 2006 BOCCARDO F.-PALMERI L.
Adjuvant chemotherapy of bladder cancer.
Ann. Oncol. 17(suppl):v129/v132, 2006
PubMed Abstract BOCCARDO F.-PUNTONI M.-GUGLIELMINI P.-RUBAGOTTI A.
Enterolactone as a risk factor for breast cancer: a review of the published evidence.
Clin. Chim. Acta 365:58/67, 2006
PubMed Abstract BOCCARDO F.-RUBAGOTTI A.-BATTAGLIA M.-ZATTONI F.-BERTACCINI A.-ROMAGNOLI A.-CONTI G.
Influence of bicalutamide with or without tamoxifen or anastrozole on insulin like growth factor 1 and binding proteins in prostate
cancer patients.
Int. J. Biol. Markers 21:123/126, 2006
PubMed Abstract BOCCARDO F.-RUBAGOTTI A.-GUGLIELMINI P.-FINI A.-PALADINI G.-MESITI M.-RINALDINI M.-SCALI S.-PORPIGLIA M.-BENEDETTO C.-RESTUCCIA N.-
BUZZI F.-FRANCHI R.-MASSIDDA B.-DISTANTE V.-AMADORI D.-SISMONDI P.
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the italian tamoxifen
anastrozole (ITA) trial.
Ann. Oncol. 17(suppl):vii10/vii14, 2006
PubMed Abstract CORADEGHINI R.-BARBORO P.-RUBAGOTTI A.-BOCCARDO F.-PARODI S.-CARMIGNANI G.-D'ARRIGO C.-PATRONE E.-BALBI C.
Differential expression of nuclear lamins in normal and cancerous prostate tissues.
Oncol. Rep. 15:609/613, 2006
PubMed Abstract DANZY S.-SU C.-PARK S.-LI S.-FERRARIS A.-LY H.
Absence of pathogenic mutations of the human telomerase RNA gene (hTERC) in patients with chronic myeloproliferative disorders.
Letter.
Leukemia 20:893/894, 2006
PubMed Abstract DEL MASTRO L.-CATZEDDU T.-BONI L.-BELL C.-SERTOLI M.R.-BIGHIN C.-CLAVAREZZA M.-TESTA D.-VENTURINI M.
Prevention of chemotherapy induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.
Ann. Oncol. 17:74/78, 2006
PubMed Abstract GALMOZZI F.-RUBAGOTTI A.-ROMAGNOLI A.-CARMIGNANI G.-PERDELLI L.-GATTESCHI B.-BOCCARDO F.
Prognostic value of cell cycle regulatory proteins in muscle infiltrating bladder cancer.
J. Cancer Res. Clin. Oncol. 132:757/764, 2006
PubMed Abstract GHIORZO P.-GARGIULO S.-PASTORINO L.-NASTI S.-CUSANO R.-BRUNO W.-GLIORI S.-SERTOLI M.R.-BURRONI A.-SAVARINO V.-GENSINI F.-SESTINI R.-QUEIROLO P.-GOLDSTEIN A.-BIANCHI SCARRA' G.
Impact of E27X, a novel CDKN2A germ line mutation, on p16 and p14ARF expression in italian melanoma families displaying pancreatic cancer and neuroblastoma.
Hum. Mol. Genet.15:2682/2689, 2006
PubMed Abstract JONAT W.-GNANT M.-BOCCARDO F.-KAUFMANN M.-RUBAGOTTI A.-ZUNA I.-GREENWOOD M.-JAKESZ R.
Effectiveness of switching from adjuvant tamoxifen to anastrozole in postmenopausal women with hormone sensitive early stage breast cancer: a meta analysis.
Lancet Oncol. 7:991/996, 2006
PubMed Abstract MIGLIETTA L.-FRANZONE P.-CENTURIONI M.G.-BONI L.-TACCHINI L.-COSSO M.-BOCCARDO F.-FERRARINI M.-BRUZZONE M.
A phase II trial with cisplatin/paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally
advanced or recurrent cervical cancer.
Oncology (Basel) 70:19/24, 2006
PubMed Abstract
RUBAGOTTI A.-MARTORANA G.-BOCCARDO F.
Epidemiology of kidney cancer.
Eur. Urol. 5(suppl):558/565, 2006 TOMASELLO L.-GARDIN G.-BOCCARDO F.
Secondary breast angiosarcoma: lethal response to anti angiogenic therapy with paclitaxel chemotherapy. A case report.
Anticancer Res. 26:4775/4778, 2006
PubMed Abstract
Per le pubblicazioni 2000-2005 del personale della struttura vedere gli
elenchi generali.
|
Presentazione della struttura